Projects per year
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are debilitating multisystemic conditions sharing similarities in immune dysregulation and cellular signaling pathways contributing to the pathophysiology. In this study, immune exhaustion gene expression was investigated in participants with ME/CFS or long COVID concurrently. RNA was extracted from peripheral blood mononuclear cells isolated from participants with ME/CFS (n = 14), participants with long COVID (n = 15), and healthy controls (n = 18). Participants with ME/CFS were included according to Canadian Consensus Criteria. Participants with long COVID were eligible according to the case definition for "Post COVID-19 Condition" published by the World Health Organization. RNA was analyzed using the NanoString nCounter Immune Exhaustion gene expression panel. Differential gene expression analysis in ME/CFS revealed downregulated IFN signaling and immunoglobulin genes, and this suggested a state of immune suppression. Pathway analysis implicated dysregulated macrophage activation, cytokine production, and immunodeficiency signaling. Long COVID samples exhibited dysregulated expression of genes regarding antigen presentation, cytokine signaling, and immune activation. Differentially expressed genes were associated with antigen presentation, B cell development, macrophage activation, and cytokine signaling. This investigation elucidates the intricate role of both adaptive and innate immune dysregulation underlying ME/CFS and long COVID, emphasizing the potential importance of immune exhaustion in disease progression.
Original language | English |
---|---|
Article number | e183810 |
Number of pages | 19 |
Journal | JCI Insight |
Volume | 9 |
Issue number | 20 |
DOIs | |
Publication status | Published - 22 Oct 2024 |
Fingerprint
Dive into the research topics of 'Immune exhaustion in ME/CFS and long COVID'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Ion channel dysfunction in the pathophysiology of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: diagnostic biomarkers, therapeutic targets and treatments
Marshall-Gradisnik, S. (Investigator 01), Staines, D. (Investigator 02), Hool, L. (Investigator 03), Nyholt, D. (Investigator 04), Muraki, K. (Investigator 05), Zalewski, P. (Investigator 06), Graves, S. (Investigator 07), Newton, J. (Investigator 08) & Cabanas, H. (Investigator 09)
NHMRC National Health and Medical Research Council
1/02/21 → 31/01/25
Project: Research